## AXON: Axon Enterprise, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 2.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($506.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Anacortes approves $136,435 contract for Axon Model 10 tasers for police**
- Source: Citizen Portal AI | 20251217T004438 | Bullish | Relevance: 100%
- The Anacortes City Council has approved a $136,435, five-year contract with Axon Enterprise Inc. for new Model 10 tasers to replace their outdated X26 models. Police Chief Floyd cited the Model 10's expanded range and de-escalation features, emphasizing tasers as a mid-level force option with rare deployment. Supporters highlighted the necessity due to lack of manufacturer support for current devices and the potential for reducing deadly-force encounters.

**2. Strength in Software & Services Unit Drives Axon: Can It Sustain?**
- Source: TradingView â€” Track All Markets | 20251216T150808 | Bullish | Relevance: 100%
- Axon Enterprise, Inc.'s Software & Services segment is a major growth driver, with revenues up 39.6% year-over-year in the first nine months of 2025, fueled by increased user adoption, premium add-on features, and strong retention. The company raised its full-year 2025 revenue guidance due to this momentum, expecting approximately 31% year-over-year growth. However, despite strong operational performance, Axon's shares have declined and it trades at a high forward P/E ratio compared to its industry peers.

**3. AXON: Morgan Stanley Lowers Price Target to $713, Maintains Overweight Rating | AXON Stock News**
- Source: GuruFocus | 20251217T144100 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley recently lowered its price target for Axon Enterprise (AXON) to $713 from $760, while maintaining an "Overweight" rating. This adjustment reflects continued analyst scrutiny, with several other firms also modifying their price targets for AXON in late 2025. Despite the lowered target, the average analyst price target suggests a significant upside from the current trading price.

**4. What Makes Axon Enterprise (AXON) a Strong Investment?**
- Source: Insider Monkey | 20251217T083100 | Bullish | Relevance: 100%
- Sands Capital Global Growth Fund highlighted Axon Enterprise, Inc. (NASDAQ: AXON) in its Q3 2025 investor letter, noting its strong business performance driven by public-safety technology like body cameras, software, and TASER devices. Despite a recent stock decline, the company reported significant revenue growth, expanded gross and adjusted EBITDA margins, and strengthened its AI leadership through acquisitions. Axon Enterprise continues to show durable momentum, although other AI stocks might offer quicker, higher returns.

**5. Strength in Software & Services Unit Drives Axon: Can It Sustain?**
- Source: Yahoo Finance | 20251216T150758 | Somewhat-Bullish | Relevance: 100%
- Axon Enterprise, Inc.'s Software & Services segment is a significant growth driver, with its revenues surging due to increased user adoption, strong demand for digital evidence management, and premium add-on features. The company's enhanced guidance for 2025 reflects this momentum, supported by new product innovations and robust customer retention. While the segment performs strongly, Axon's stock has underperformed its industry, and its valuation carries a high price-to-earnings ratio compared to peers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $713 | $760 | -6% |
| 2025-11-17 | RBC Capital | $860 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-11-17 | RBC Capital | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 20 ($53.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+4.2%)
- Blackrock Inc.: 10.4% (+8.3%)
- State Street Corpora: 4.3% (+6.4%)
- FMR, LLC: 3.8% (+2.1%)
- Geode Capital Manage: 2.8% (+5.7%)

### Key Risks

1. Heavy insider selling: $53M sold (20 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 18.9% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.86 signals overvaluation risk, limited margin of safety. Forward P/E 72.9x stretched relative to 19% growth. Balance sheet: strong liquidity (3.1x). Revenue growth strong at 25% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($53.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $43.4B |
| Beta | 1.40 |
| 52W Range | $469.24 - $885.92 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.86 |
| Forward P/E | 72.9 |
| Current P/E | 87.1 |
| YoY Growth | 19.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.1% to 1.6% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.0% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. MACD histogram positive (6.88), confirming momentum. RSI neutral at 42. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.56% (CS: 40) | Neutral |
| RSI_14 | 41.7 | Neutral |
| MACD Histogram | 6.88 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 0.890x | Below |
| vs SMA200 | 0.811x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $550.00
- **Stop Loss:** $506.84 (7.8% risk)
- **Target:** $593.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 25
- **Position Value:** $13,750.00
- **Portfolio %:** 13.75%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-24 (Est: $1.60)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.54 | $1.17 | -24.1% |
| 2025Q2 | $1.46 | $2.12 | +45.0% |
| 2025Q1 | $1.28 | $1.41 | +10.2% |
| 2024Q4 | $1.40 | $2.08 | +48.2% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*